| REGISTERED NUMBER: 11885403 (England and Wales) |
| UNITED HEALTH GROUP 2 LIMITED |
| GROUP STRATEGIC REPORT, |
| REPORT OF THE DIRECTORS AND |
| CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| REGISTERED NUMBER: 11885403 (England and Wales) |
| UNITED HEALTH GROUP 2 LIMITED |
| GROUP STRATEGIC REPORT, |
| REPORT OF THE DIRECTORS AND |
| CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| Page |
| Company Information | 1 |
| Group Strategic Report | 2 |
| Report of the Directors | 3 |
| Report of the Independent Auditors | 4 | to | 6 |
| Consolidated Income Statement | 7 |
| Consolidated Other Comprehensive Income | 8 |
| Consolidated Statement of Financial Position | 9 |
| Company Statement of Financial Position | 10 |
| Consolidated Statement of Changes in Equity | 11 |
| Company Statement of Changes in Equity | 12 |
| Consolidated Statement of Cash Flows | 13 |
| Notes to the Consolidated Statement of Cash Flows | 14 |
| Notes to the Consolidated Financial Statements | 15 | to | 26 |
| UNITED HEALTH GROUP 2 LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| SENIOR STATUTORY AUDITOR: | Tara Bellamy FCA |
| AUDITORS: |
| 4 Henley Way |
| Doddington Road |
| Lincoln |
| Lincolnshire |
| LN6 3QR |
| BANKERS: | HSBC Bank Plc |
| 221 High Street |
| Lincoln |
| Lincolnshire |
| LN1 1TS |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| The directors present their strategic report of the company and the group for the year ended 31 January 2026. |
| REVIEW OF BUSINESS |
| The Group delivered a strong financial performance during the year ended 31 January 2026. |
| Turnover increased to £8.72 million from £6.10 million, representing growth of approximately 43%. Profit before taxation increased significantly to £3.16 million (2025: £1.29 million), while net assets increased to £8.62 million (2025: £6.27 million). These results reflect continued demand for the Group's specialist residential and educational services together with strong occupancy levels and operational efficiency improvements. |
| The Group generated operating profit of £3.42 million (2025: £1.60 million) and ended the year with cash balances of £6.36 million (2025: £0.30 million). The directors consider these results to be highly satisfactory and reflective of the strength of the underlying business model. |
| Key performance indicators |
| KPI | 2026 | 2025 |
| Revenue | £8.72m | £6.10m |
| Operating profit | £3.42m | £1.60m |
| Profit before tax | £3.16m | £1.29m |
| Net assets | £8.62m | £6.27m |
| Cash balances | £6.36m | £0.30m |
| Financial position |
| At the year end the Group had net assets of £8.62 million and cash balances of £6.36 million. The Group also successfully refinanced part of its banking facilities during the year, resulting in improved liquidity and a stronger current asset position. The directors believe the Group remains well positioned to support future growth opportunities and investment in its children's services and educational operations. |
| PRINCIPAL RISKS AND UNCERTAINTIES |
| The principal risks affecting the Group include: |
| -funding pressure within the care and education sectors; |
| -recruitment and retention of suitably qualified staff; |
| -regulatory compliance with Ofsted and other sector-specific requirements; |
| -inflationary pressures affecting employment and operating costs; |
| -changes in local authority commissioning arrangements. |
| The Group mitigates these risks through structured governance, regular financial monitoring, staff development programmes, quality assurance procedures and maintenance of strong relationships with commissioning authorities. |
| FUTURE DEVELOPMENT |
| The directors intend to continue growing the Group through organic development of existing services and investment in additional capacity where demand exists. The Group expects demand for specialist residential care and education services to remain strong and continues to evaluate opportunities to expand both service offerings and geographical coverage. |
| GOING CONCERN |
| The directors have reviewed budgets, forecasts and projected cash flows covering a period of at least twelve months from the date of approval of the financial statements. Having considered available banking facilities, trading performance and forecast cash generation, the directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on the going concern basis. |
| ON BEHALF OF THE BOARD: |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| REPORT OF THE DIRECTORS |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| The directors present their report with the financial statements of the company and the group for the year ended 31 January 2026. |
| PRINCIPAL ACTIVITY |
| The principal activity of the group in the year under review was that of the provision of residential, therapeutic and educational services for children with emotional and behavioural difficulties. |
| DIVIDENDS |
| No dividends will be distributed for the year ended 31 January 2026. |
| DIRECTORS |
| The directors shown below have held office during the whole of the period from 1 February 2025 to the date of this report. |
| STATEMENT OF DIRECTORS' RESPONSIBILITIES |
| The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations. |
| Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to: |
| - | select suitable accounting policies and then apply them consistently; |
| - | make judgements and accounting estimates that are reasonable and prudent; |
| - | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
| The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
| STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
| So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information. |
| ON BEHALF OF THE BOARD: |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| UNITED HEALTH GROUP 2 LIMITED |
| Opinion |
| We have audited the financial statements of United Health Group 2 Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 January 2026 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Statement of Financial Position, Company Statement of Financial Position, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Statement of Cash Flows and Notes to the Consolidated Statement of Cash Flows, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
| In our opinion the financial statements: |
| - | give a true and fair view of the state of the group's and of the parent company affairs as at 31 January 2026 and of the group's profit for the year then ended; |
| - | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
| - | have been prepared in accordance with the requirements of the Companies Act 2006. |
| Basis for opinion |
| We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
| Conclusions relating to going concern |
| In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
| Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
| Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report. |
| Other information |
| The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon. |
| Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. |
| In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. |
| Opinions on other matters prescribed by the Companies Act 2006 |
| In our opinion, based on the work undertaken in the course of the audit: |
| - | the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
| - | the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| UNITED HEALTH GROUP 2 LIMITED |
| Matters on which we are required to report by exception |
| In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors. |
| We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
| - | adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or |
| - | the parent company financial statements are not in agreement with the accounting records and returns; or |
| - | certain disclosures of directors' remuneration specified by law are not made; or |
| - | we have not received all the information and explanations we require for our audit. |
| Responsibilities of directors |
| As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
| In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so. |
| Auditors' responsibilities for the audit of the financial statements |
| Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
| The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: |
| We have identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our general commercial experience, knowledge of the sector, a review of regulatory and legal correspondence and through discussions with Directors and other management obtained as part of the work required by auditing standards. We have also discussed with the Directors and other management the policies and procedures relating to compliance with laws and regulations. We communicated laws and regulations throughout the team and remained alert to any indications of non-compliance throughout the audit. |
| The potential impact of different laws and regulations varies considerably. Firstly, the company is subject to laws and regulations that directly impact the financial statements (for example financial reporting legislation) and we have assessed the extent of compliance with such laws as part of our financial statements audit. We evaluated management incentives and opportunities for fraudulent manipulation of the financial statements, (including risk of override of controls) and determined that the principal risks were related to management bias in accounting estimate and judgemental areas of the financial statements such as depreciation of tangible fixed asset, as well as the risk of inappropriate journal entries to increase reported profitability. Audit procedures performed by the engagement team included the identification and testing of material and unusual journal entries and challenging management on key accounting estimates, assumptions and judgements made in preparation of the financial statements. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| UNITED HEALTH GROUP 2 LIMITED |
| Secondly, the company is subject to other laws and regulations where the consequence for non-compliance could have a material effect on the amounts or disclosures in the financial statements. We identified compliance with Ofsted regulations as most likely to have such an effect. |
| Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the Directors and other management and inspection. We inspected the latest Ofsted inspection reports from visits in the year for any instances of non-compliance and discussed with management the impact of the outcomes of these visits on operations of the children's homes. Through these procedures, if we became aware of any non-compliance, we considered the impact on the procedures performed on the related financial statement items. |
| Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. The further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. As with any audit, there is a greater risk of non-detection of irregularities as these may involve collusion, intentional omissions of the override of internal controls. |
| We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations. |
| A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors. |
| Use of our report |
| This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
| for and on behalf of |
| 4 Henley Way |
| Doddington Road |
| Lincoln |
| Lincolnshire |
| LN6 3QR |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| CONSOLIDATED INCOME STATEMENT |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 2026 | 2025 |
| as restated |
| Notes | £ | £ |
| TURNOVER | 8,719,948 | 6,099,157 |
| Cost of sales | 3,461,494 | 2,845,626 |
| GROSS PROFIT | 5,258,454 | 3,253,531 |
| Administrative expenses | 1,937,701 | 1,680,784 |
| 3,320,753 | 1,572,747 |
| Other operating income | 97,747 | 23,667 |
| OPERATING PROFIT | 4 | 3,418,500 | 1,596,414 |
| Interest payable and similar expenses | 6 | 254,740 | 307,252 |
| PROFIT BEFORE TAXATION | 3,163,760 | 1,289,162 |
| Tax on profit | 7 | 815,207 | 282,853 |
| PROFIT FOR THE FINANCIAL YEAR |
| Profit attributable to: |
| Owners of the parent | 2,348,553 | 1,006,309 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| CONSOLIDATED OTHER COMPREHENSIVE INCOME |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 2026 | 2025 |
| as restated |
| Notes | £ | £ |
| PROFIT FOR THE YEAR | 2,348,553 | 1,006,309 |
| OTHER COMPREHENSIVE INCOME | - | - |
| TOTAL COMPREHENSIVE INCOME FOR THE YEAR | 2,348,553 |
| Prior year adjustment | 1,119,602 |
| TOTAL COMPREHENSIVE INCOME SINCE LAST ANNUAL REPORT |
2,125,911 |
| Total comprehensive income attributable to: |
| Owners of the parent | 2,348,553 | 2,125,911 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| CONSOLIDATED STATEMENT OF FINANCIAL POSITION |
| 31 JANUARY 2026 |
| 2026 | 2025 |
| as restated |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 10 | - | - |
| Tangible assets | 11 | 8,256,793 | 7,332,401 |
| Investments | 12 | - | - |
| 8,256,793 | 7,332,401 |
| CURRENT ASSETS |
| Debtors | 13 | 8,532,117 | 12,938,076 |
| Cash at bank and in hand | 6,359,292 | 300,553 |
| 14,891,409 | 13,238,629 |
| CREDITORS |
| Amounts falling due within one year | 14 | 10,409,432 | 14,254,856 |
| NET CURRENT ASSETS/(LIABILITIES) | 4,481,977 | (1,016,227 | ) |
| TOTAL ASSETS LESS CURRENT LIABILITIES | 12,738,770 | 6,316,174 |
| CREDITORS |
| Amounts falling due after more than one year | 15 | (4,072,084 | ) | - |
| PROVISIONS FOR LIABILITIES | 19 | (49,457 | ) | (47,498 | ) |
| NET ASSETS | 8,617,229 | 6,268,676 |
| CAPITAL AND RESERVES |
| Called up share capital | 20 | 48,130 | 48,130 |
| Share premium | 21 | 6,705 | 6,705 |
| Capital redemption reserve | 21 | 47,380 | 47,380 |
| Retained earnings | 21 | 8,515,014 | 6,166,461 |
| SHAREHOLDERS' FUNDS | 8,617,229 | 6,268,676 |
| The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2026 and were signed on its behalf by: |
| P J Pearson - Director |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| COMPANY STATEMENT OF FINANCIAL POSITION |
| 31 JANUARY 2026 |
| 2026 | 2025 |
| as restated |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 10 |
| Tangible assets | 11 |
| Investments | 12 |
| CURRENT ASSETS |
| Debtors | 13 |
| Cash at bank and in hand |
| CREDITORS |
| Amounts falling due within one year | 14 |
| NET CURRENT LIABILITIES | ( |
) | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year | 15 | ( |
) |
| PROVISIONS FOR LIABILITIES | 19 | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 20 |
| Share premium | 21 |
| Capital redemption reserve | 21 |
| Retained earnings | 21 |
| SHAREHOLDERS' FUNDS |
| Company's loss for the financial year | (278,300 | ) | (187,142 | ) |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| CONSOLIDATED STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| Called up | Capital |
| share | Retained | Share | redemption | Total |
| capital | earnings | premium | reserve | equity |
| £ | £ | £ | £ | £ |
| Balance at 1 February 2024 | 47,380 | 4,040,550 | - | 47,380 | 4,135,310 |
| Prior year adjustment | - | 1,119,602 | - | - | 1,119,602 |
| As restated | 47,380 | 5,160,152 | - | 47,380 | 5,254,912 |
| Changes in equity |
| Issue of share capital | 750 | - | 6,705 | - | 7,455 |
| Total comprehensive income | - | 1,006,309 | - | - | 1,006,309 |
| Balance at 31 January 2025 | 48,130 | 6,166,461 | 6,705 | 47,380 | 6,268,676 |
| Changes in equity |
| Total comprehensive income | - | 2,348,553 | - | - | 2,348,553 |
| Balance at 31 January 2026 | 48,130 | 8,515,014 | 6,705 | 47,380 | 8,617,229 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| COMPANY STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| Called up | Capital |
| share | Retained | Share | redemption | Total |
| capital | earnings | premium | reserve | equity |
| £ | £ | £ | £ | £ |
| Balance at 1 February 2024 |
| Changes in equity |
| Issue of share capital | - | - |
| Total comprehensive income | - | ( |
) | - | ( |
) |
| Balance at 31 January 2025 |
| Changes in equity |
| Total comprehensive income | - | ( |
) | - | ( |
) |
| Balance at 31 January 2026 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| CONSOLIDATED STATEMENT OF CASH FLOWS |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 2026 | 2025 |
| as restated |
| Notes | £ | £ |
| Cash flows from operating activities |
| Cash generated from operations | 1 | 8,160,613 | 2,515,744 |
| Interest paid | (254,740 | ) | (305,708 | ) |
| Tax paid | (274,888 | ) | (455,583 | ) |
| Net cash from operating activities | 7,630,985 | 1,754,453 |
| Cash flows from investing activities |
| Purchase of tangible fixed assets | (1,108,146 | ) | (303,593 | ) |
| Sale of intangible fixed assets | - | (1,119,602 | ) |
| Sale of tangible fixed assets | - | 4,588 |
| Grant income | 97,747 | - |
| Net cash from investing activities | (1,010,399 | ) | (1,418,607 | ) |
| Cash flows from financing activities |
| New loans in year | 4,360,000 | - |
| Loan repayments in year | (4,093,501 | ) | (399,477 | ) |
| Amount introduced by directors | 23,539 | 41,795 |
| Amount withdrawn by directors | (851,885 | ) | (5,419 | ) |
| Share issue | - | 750 |
| Share premium | - | 6,705 |
| Net cash from financing activities | (561,847 | ) | (355,646 | ) |
| Increase/(decrease) in cash and cash equivalents | 6,058,739 | (19,800 | ) |
| Cash and cash equivalents at beginning of year | 2 | 300,553 | 320,353 |
| Cash and cash equivalents at end of year | 2 | 6,359,292 | 300,553 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED STATEMENT OF CASH FLOWS |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 1. | RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Profit before taxation | 3,163,760 | 1,289,162 |
| Depreciation charges | 183,754 | 179,855 |
| Profit on disposal of fixed assets | - | (1,244 | ) |
| Amortisation | - | 866,105 |
| Government grants | (97,747 | ) | - |
| Finance costs | 254,740 | 307,252 |
| 3,504,507 | 2,641,130 |
| Decrease/(increase) in trade and other debtors | 2,675,273 | (714,334 | ) |
| Increase in trade and other creditors | 1,980,833 | 588,948 |
| Cash generated from operations | 8,160,613 | 2,515,744 |
| 2. | CASH AND CASH EQUIVALENTS |
| The amounts disclosed on the Statement of Cash Flows in respect of cash and cash equivalents are in respect of these Statement of Financial Position amounts: |
| Year ended 31 January 2026 |
| 31.1.26 | 1.2.25 |
| £ | £ |
| Cash and cash equivalents | 6,359,292 | 300,553 |
| Year ended 31 January 2025 |
| 31.1.25 | 1.2.24 |
| as restated |
| £ | £ |
| Cash and cash equivalents | 300,553 | 320,353 |
| 3. | ANALYSIS OF CHANGES IN NET (DEBT)/FUNDS |
| At 1.2.25 | Cash flow | At 31.1.26 |
| £ | £ | £ |
| Net cash |
| Cash at bank and in hand | 300,553 | 6,058,739 | 6,359,292 |
| 300,553 | 6,058,739 | 6,359,292 |
| Debt |
| Debts falling due within 1 year | (4,073,501 | ) | 3,805,585 | (267,916 | ) |
| Debts falling due after 1 year | - | (4,072,084 | ) | (4,072,084 | ) |
| (4,073,501 | ) | (266,499 | ) | (4,340,000 | ) |
| Total | (3,772,948 | ) | 5,792,240 | 2,019,292 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 1. | STATUTORY INFORMATION |
| United Health Group 2 Limited is a |
| The presentation currency of the financial statements is the Pound Sterling (£). |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Basis of consolidation |
| The group financial statements consolidate the financial statements of United Health Group 2 Limited and the entities it controls (its subsidiaries) drawn up to 31 January each year. Control comprises the power to govern the financial and operating policies of the investee via control of the issued share capital of those companies. |
| Subsidiaries are consolidated from the date of their acquisition, being the date on which the group obtains control, and continue to be consolidated until the date that such control ceases. |
| The financial statements of subsidiaries are prepared for the same reporting year as the parent company, using consistent accounting policies. |
| Subsidiaries acquired during the year are consolidated under the acquisition method of accounting, whereby underlying assets and liabilities, and the consideration paid, are recorded at their fair values. The deficit of the fair value of consideration paid less than the fair value of net assets acquired is presented as negative consolidation goodwill. |
| Intercompany balances and transactions, including unrealised profits arising from intragroup transactions, have been eliminated. |
| Significant judgements and estimates |
| In the application of the group's accounting policies, management is required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. |
| The estimates and underlying assumptions are reviewed on an ongoing basis and are covered within the accounting policies: |
| (i) The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. See note 10 for the carrying amount of the property plant and equipment, and accounting policy note for the usual economic lives of each class of assets. |
| (ii) The group makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management considers factors including the current credit rating of the debtor, ageing profile of debtors and historical experience. See note 12 for the net carrying amount of the debtors and associated impairment provision. |
| (iii) The group has an obligation to pay pension benefits to certain employees. The cost of these benefits and the present value of the obligation depend on a number of factors, including; life expectancy, salary increases, asset valuations and the discount rate on corporate bonds. Management estimates these factors in determining the net pension obligation in the statement of financial position. The assumptions reflect historical experience and current trends. See note 3 for the disclosures relating to the defined contribution pension scheme. |
| Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects. |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 2. | ACCOUNTING POLICIES - continued |
| Changes in accounting estimate |
| During the year ended 31 January 2026, United Education Services Limited changed its method used for recognising revenue. Previously, annual fee income was recognised evenly over the three academic terms. The revised method recognises annual fee income based on the number of academic days in each term. The revised methodology reflects more faithfully the pattern in which educational services are delivered and consumed throughout the academic year. |
| The directors consider this to be a change in accounting estimate under UK GAAP and, accordingly, the change has been applied prospectively in the current and future periods. |
| Had the revised method been applied in the prior year, profit for the year would have increased by £55,384. |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable.The policies adopted for the recognition of turnover are as follows: |
| Rendering of services |
| When the outcome of a transaction can be estimated reliably, turnover is recognised in the period in which the services are provided and comprises residents' fees, educational fees and other ancillary services. Educational fees are measured net of VAT, all other fees are gross. |
| Where the outcome cannot be measured reliably, turnover is recognised only to the extent of the expenses recognised that are recoverable. |
| Goodwill |
| Negative goodwill arising on consolidation has been capitalised and released over a period of ten years. |
| Tangible fixed assets |
| Freehold property | - |
| Fixtures and fittings | - |
| Motor vehicles | - |
| Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. |
| Impairment of fixed assets |
| A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. |
| For the purpose of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, as estimate is made of the recoverable amount of the cash- generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that included the asset and generates cash inflows that largely independent of the cash inflows from other assets or group assets. |
| Government grants |
| Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received using the accrual model. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date. |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 2. | ACCOUNTING POLICIES - continued |
| Pension costs and other post-retirement benefits |
| The group operates defined contribution pension schemes. Contributions are recognised as an expense in the period in which they become payable. The group has no further payment obligations once contributions have been paid. |
| Leasing commitments |
| Lease payments are recognised as an expense over the lease term on a straight-line basis. |
| Financial instruments |
| The group has chosen to adopt the Sections 11 and 12 of FRS 102 in respect of financial instruments. |
| Basic financial assets, including trade and other debtors and cash and bank balances are initially recognised at transaction price, unless the arrangement constitute a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. |
| At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in the income statement. |
| Basic financial liabilities, including trade and other creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. |
| Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. |
| Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. |
| Loans and borrowings |
| Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value. |
| 3. | EMPLOYEES AND DIRECTORS |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Wages and salaries | 3,185,268 | 2,612,600 |
| Social security costs | 390,705 | 262,014 |
| Other pension costs | 86,705 | 70,203 |
| 3,662,678 | 2,944,817 |
| The average number of employees during the year was as follows: |
| 2026 | 2025 |
| as restated |
| Head office | 13 | 12 |
| Children's services | 34 | 34 |
| Education services | 44 | 32 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 3. | EMPLOYEES AND DIRECTORS - continued |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Directors' remuneration | 401,124 | 368,433 |
| Directors' pension contributions to money purchase schemes | 15,698 | 15,596 |
| The number of directors to whom retirement benefits were accruing was as follows: |
| Money purchase schemes | 5 | 5 |
| Information regarding the highest paid director is as follows: |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Emoluments etc | 111,500 | 116,000 |
| Pension contributions to money purchase schemes | 3,963 | 3,963 |
| 4. | OPERATING PROFIT |
| The operating profit is stated after charging/(crediting): |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Other operating leases | 19,733 | 17,175 |
| Depreciation - owned assets | 183,754 | 179,856 |
| Profit on disposal of fixed assets | - | (1,244 | ) |
| Goodwill amortisation | - | (253,494 | ) |
| Auditors' remuneration | 24,590 | 28,544 |
| 5. | EXCEPTIONAL ITEMS |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Exceptional items | - | (10,000 | ) |
| The exceptional item is in relation to an intercompany loan write off due to the company being dissolved. |
| 6. | INTEREST PAYABLE AND SIMILAR EXPENSES |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Bank interest | 253,129 | 305,708 |
| HMRC interest | 1,611 | 1,544 |
| 254,740 | 307,252 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 7. | TAXATION |
| Analysis of the tax charge |
| The tax charge on the profit for the year was as follows: |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Current tax: |
| UK corporation tax | 813,248 | 286,069 |
| Deferred tax | 1,959 | (3,216 | ) |
| Tax on profit | 815,207 | 282,853 |
| Reconciliation of total tax charge included in profit and loss |
| The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below: |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Profit before tax | 3,163,760 | 1,289,162 |
| Profit multiplied by the standard rate of corporation tax in the UK of 25 % (2025 - 25 %) |
790,940 |
322,291 |
| Effects of: |
| Expenses not deductible for tax purposes | 608 | 2,932 |
| Income not taxable for tax purposes | (328 | ) | - |
| Capital allowances in excess of depreciation | - | (39,154 | ) |
| Depreciation in excess of capital allowances | 22,028 | - |
| Deferred tax | 1,959 | (3,216 | ) |
| Total tax charge | 815,207 | 282,853 |
| 8. | INDIVIDUAL INCOME STATEMENT |
| As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements. |
| 9. | PRIOR YEAR ADJUSTMENT |
| During the year, the directors reviewed the accounting treatment of negative goodwill recognised on a previous business combination. The balance had previously been amortised over a period of ten years. |
| Following this review, it was concluded that the previous treatment did not accurately reflect the economic life of the underlying assets that resulted in this negative goodwill . A prior year adjustment has therefore been made to fully write down the remaining balance of the negative goodwill, with the comparative figures restated accordingly. |
| As a result of these adjustments, total fixed assets and opening reserves have increased by £1,119,602. This adjustment has no impact on the profit/loss in the current period. |
| This adjustment brings the financial statements into line with the requirements of FRS 102 in respect of the accounting treatment of negative goodwill. |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 10. | INTANGIBLE FIXED ASSETS |
| Group |
| Goodwill |
| £ |
| COST |
| At 1 February 2025 |
| and 31 January 2026 | (1,415,342 | ) |
| AMORTISATION |
| At 1 February 2025 |
| and 31 January 2026 | (1,415,342 | ) |
| NET BOOK VALUE |
| At 31 January 2026 | - |
| At 31 January 2025 | - |
| Negative goodwilll arose on the purchase of United Children's Services Limited due to the net assets acquired being in excess of the consideration given. |
| 11. | TANGIBLE FIXED ASSETS |
| Group |
| Fixtures |
| Freehold | and | Motor |
| property | fittings | vehicles | Totals |
| £ | £ | £ | £ |
| COST |
| At 1 February 2025 | 7,477,388 | 941,920 | 213,728 | 8,633,036 |
| Additions | 1,022,846 | 45,035 | 40,265 | 1,108,146 |
| At 31 January 2026 | 8,500,234 | 986,955 | 253,993 | 9,741,182 |
| DEPRECIATION |
| At 1 February 2025 | 270,725 | 849,176 | 180,734 | 1,300,635 |
| Charge for year | 103,037 | 54,253 | 26,464 | 183,754 |
| At 31 January 2026 | 373,762 | 903,429 | 207,198 | 1,484,389 |
| NET BOOK VALUE |
| At 31 January 2026 | 8,126,472 | 83,526 | 46,795 | 8,256,793 |
| At 31 January 2025 | 7,206,663 | 92,744 | 32,994 | 7,332,401 |
| Included in cost of land and buildings is freehold land of £2,075,000 (2025 - £2,075,000) which is not depreciated. |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 11. | TANGIBLE FIXED ASSETS - continued |
| Company |
| Fixtures |
| Freehold | and | Motor |
| property | fittings | vehicles | Totals |
| £ | £ | £ | £ |
| COST |
| At 1 February 2025 |
| Additions |
| At 31 January 2026 |
| DEPRECIATION |
| At 1 February 2025 |
| Charge for year |
| At 31 January 2026 |
| NET BOOK VALUE |
| At 31 January 2026 |
| At 31 January 2025 |
| Included in cost of land and buildings is freehold land of £ 2,075,000 (2025 - £ 2,075,000 ) which is not depreciated. |
| 12. | FIXED ASSET INVESTMENTS |
| Company |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1 February 2025 |
| and 31 January 2026 |
| NET BOOK VALUE |
| At 31 January 2026 |
| At 31 January 2025 |
| The group or the company's investments at the Statement of Financial Position date in the share capital of companies include the following: |
| Subsidiaries |
| Registered office: Unit J The Quays, Burton Waters, Lincoln, LN1 2XG |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2026 | 2025 |
| £ | £ |
| Aggregate capital and reserves |
| Profit for the year |
| United Children's Services Limited owns 100% of the share capital of United Education Services Limited. |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 12. | FIXED ASSET INVESTMENTS - continued |
| Registered office: Unit J The Quays, Burton Waters, Lincoln, LN1 2XG |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2026 | 2025 |
| £ | £ |
| Aggregate capital and reserves |
| Profit for the year |
| 13. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| Group | Company |
| 2026 | 2025 | 2026 | 2025 |
| as restated | as restated |
| £ | £ | £ | £ |
| Trade debtors | 2,288,544 | 1,817,140 |
| Amounts owed by group undertakings | - | - |
| Other debtors | 6,132,294 | 11,103,654 |
| VAT | - | - |
| Prepayments and accrued income | 111,279 | 17,282 |
| 8,532,117 | 12,938,076 |
| Amounts owed from group undertakings are unsecured, interest free and repayable on demand. |
| 14. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| Group | Company |
| 2026 | 2025 | 2026 | 2025 |
| as restated | as restated |
| £ | £ | £ | £ |
| Bank loans and overdrafts (see note 16) | 267,916 | 4,073,501 |
| Trade creditors | 91,906 | 113,368 |
| Amounts owed to group undertakings | - | - |
| Taxation | 669,248 | 130,888 |
| Other taxes and social security | 90,603 | 61,641 |
| VAT | 592,564 | 270,541 | - | - |
| Other creditors | 353,663 | 342,296 |
| Directors' current accounts | 7,314,212 | 8,142,558 | 7,311,125 | 8,139,471 |
| Accruals and deferred income | 1,029,320 | 1,120,063 |
| 10,409,432 | 14,254,856 |
| Amounts owed to group undertakings are unsecured, interest free and repayable on demand. |
| 15. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| Group | Company |
| 2026 | 2025 | 2026 | 2025 |
| as restated | as restated |
| £ | £ | £ | £ |
| Bank loans (see note 16) | 4,072,084 | - |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 16. | LOANS |
| An analysis of the maturity of loans is given below: |
| Group | Company |
| 2026 | 2025 | 2026 | 2025 |
| as restated | as restated |
| £ | £ | £ | £ |
| Amounts falling due within one year or on | demand: |
| Bank loans | 267,916 | 4,073,501 |
| Amounts falling due between one and two years: |
| Bank loans - 1-2 years | 364,042 | - |
| Amounts falling due between two and five years: |
| Bank loans - 2-5 years | 3,708,042 | - |
| 17. | LEASING AGREEMENTS |
| Minimum lease payments fall due as follows: |
| Group |
| Non-cancellable |
| operating leases |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Within one year | - | 18,000 |
| Between one and five years | - | 3,000 |
| - | 21,000 |
| Company |
| Non-cancellable |
| operating leases |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Within one year |
| Between one and five years |
| 18. | SECURED DEBTS |
| The following secured debts are included within creditors: |
| Group | Company |
| 2026 | 2025 | 2026 | 2025 |
| as restated | as restated |
| £ | £ | £ | £ |
| Bank loans | 4,340,000 | 4,073,501 |
| HSBC UK Bank Plc holds a fixed and floating charge over all the assets of the parent and one of the subsidiaries. |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 19. | PROVISIONS FOR LIABILITIES |
| Group | Company |
| 2026 | 2025 | 2026 | 2025 |
| as restated | as restated |
| £ | £ | £ | £ |
| Deferred tax |
| Accelerated capital allowances | 49,457 | 47,498 |
| Group |
| Deferred |
| tax |
| £ |
| Balance at 1 February 2025 | 47,498 |
| Charge to Income Statement during year | 1,959 |
| Balance at 31 January 2026 | 49,457 |
| Company |
| Deferred |
| tax |
| £ |
| Balance at 1 February 2025 |
| Charge to Income Statement during year |
| Balance at 31 January 2026 |
| 20. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2026 | 2025 |
| value: | as restated |
| £ | £ |
| Ordinary | £0.50 | 48,130 | 48,130 |
| 21. | RESERVES |
| Group |
| Capital |
| Retained | Share | redemption |
| earnings | premium | reserve | Totals |
| £ | £ | £ | £ |
| At 1 February 2025 | 6,166,461 | 6,705 | 47,380 | 6,220,546 |
| Profit for the year | 2,348,553 | 2,348,553 |
| At 31 January 2026 | 8,515,014 | 6,705 | 47,380 | 8,569,099 |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 21. | RESERVES - continued |
| Company |
| Capital |
| Retained | Share | redemption |
| earnings | premium | reserve | Totals |
| £ | £ | £ | £ |
| At 1 February 2025 | 1,097,370 |
| Deficit for the year | ( |
) | ( |
) |
| At 31 January 2026 | 819,070 |
| Retained earnings |
| Includes all current and prior period retained profits and losses less dividends paid. All amounts are distributable. |
| Capital redemption reserve |
| This reserve arose on the purchase of the parent's own Ordinary B shares. |
| Share premium |
| This reserve arose on the purchase of additional shares for above market value. |
| 22. | PENSION COMMITMENTS |
| Assets of the group's pension scheme are held separately in an independently administered fund. At the financial reporting date the group had pension commitments of £17,305 (2025 - £11,090). |
| 23. | CONTINGENT LIABILITIES |
| The group is a party to a composite cross guarantee given to the HSBC Bank Plc between Manor Homes (Yorkshire) Limited, United Children's Services Limited, United Education Services Limited, United Health Group 2 Limited and Manor Homes Property Company Limited. |
| 24. | RELATED PARTY DISCLOSURES |
| Key management personnel of the entity or its parent (in the aggregate) |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Amount due to related party | 7,426,792 | 8,303,151 |
| Other related parties |
| 2026 | 2025 |
| as restated |
| £ | £ |
| Amount due from related party | 6,132,294 | 11,103,654 |
| During the year, a total of key management personnel compensation of £ 481,657 (2025 - £ 434,029 ) was paid. |
| 25. | ULTIMATE CONTROLLING PARTY |
| The ultimate controlling party is P J Pearson. |
| UNITED HEALTH GROUP 2 LIMITED (REGISTERED NUMBER: 11885403) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 JANUARY 2026 |
| 26. | SHARE-BASED PAYMENT TRANSACTIONS |
| The company has a share option scheme for key employees. Options are exercisable at a price equal to the average market price of the company's shares on the date of grant. |
| 2024 Options |
| The vesting period is 5 years, options can be exercised when the exercise conditions have been met, which require the company to hit a certain level of EBITDA. The exercise of the options is also dependent on eligible executives remaining in employment over the vesting period. |
| If an individual ceases to be an employee for any reason, the board may permit them to exercise all or any part of the option. If the board does not make such a decision after 90 days after the termination of the employment, the option will lapse. |